investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Anne Arundel Dermatology Names Vincent Bradley as Chief Executive Officer

Gracie Gottlieb | 2 August, 2023

Anne Arundel Dermatology, a leading provider of medical, surgical, and cosmetic dermatological services, is pleased to announce the appointment of Vincent Bradley as Chief Executive Officer. With over 20 years of experience in healthcare service organizations, Mr. Bradley brings a wealth of knowledge and expertise to his new role.

Throughout his career, Vincent Bradley has worked in various healthcare specialties, including primary care, women's health, and veterinary medicine. As an entrepreneur and business operator, he has successfully led scaled, multi-unit healthcare provider platforms by implementing strategic growth plans and fostering strong team dynamics.

In his new position, Mr. Bradley is eager to join the Anne Arundel Dermatology team and build upon the company's exceptional track record of clinical excellence and successful collaboration with affiliated practices. He believes that by aligning with their platform for business support, AAD can establish itself as the preferred partner for healthcare providers focused on delivering high-quality, comprehensive care to their patients while alleviating their administrative burdens.

Dan Harknett, Partner at Ridgemont Equity Partners, the private equity firm that Anne Arundel Dermatology is a portfolio company of, spoke highly of Vincent Bradley, stating, "Vincent is an impactful leader and brings an extensive operational background from his experience running other high-growth healthcare service organizations. We look forward to working together to accomplish our shared goals for AAD."

Ridgemont Equity Partners is actively seeking partnerships with dermatologists in the Mid-Atlantic and Southeastern states. Their aim is to offer physicians and their staff the necessary tools and resources to provide a comprehensive suite of services and deliver the best patient experience.

As a leading provider of dermatological services, Anne Arundel Dermatology operates in Maryland, Virginia, North Carolina, Florida, Tennessee, Pennsylvania, and Georgia. With approximately 150 locations and 300 providers, they offer a wide range of dermatologic services, including general dermatology, advanced treatment options for skin cancer, and cosmetic procedures.

About Ridgemont Equity Partners

Ridgemont Equity Partners is a Charlotte-based private equity firm specializing in the middle market. For three decades, they have provided buyout and growth capital to industry-leading companies in various sectors, including business and tech-enabled services, industrial growth, and healthcare. The firm's principals have honed a proven, industry-focused model focused on building distinctive middle market companies.

For more information about Ridgemont Equity Partners, please visit their website at www.ridgemontep.com.

In conclusion, the appointment of Vincent Bradley as Chief Executive Officer of Anne Arundel Dermatology marks an exciting new chapter for the company. With his extensive experience and leadership skills, Mr. Bradley is poised to lead the team in continuing to provide excellent dermatological services and fostering successful partnerships with healthcare providers. As a portfolio company of Ridgemont Equity Partners, AAD is well-positioned for growth and expansion in the Mid-Atlantic and Southeastern states.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.